His investigation of Theranos, Inc. raised serious doubts about claims by the firm and its celebrated 31-year-old founder, Elizabeth Holmes, that its new procedure for drawing and testing blood was a transformational medical breakthrough in wide use at the firm’s labs.
Carreyrou’s well-researched stories, reported in the face of threats of lawsuits and efforts to pressure some sources to back off of their accounts, led to a re-evaluation of Theranos’ prospects among investors and have been followed by regulatory actions against the company and widespread discussion that publications and institutions from Fortune and The New Yorker to Harvard and the White House may have been too quick to hail Holmes, a Stanford dropout whose personal wealth at the height of her startup’s rise was an estimated $4.5 billion, as a success story in the tradition of Steve Jobs, Bill Gates and Mark Zuckerberg.
To see all of the winners, go here.
Rahat Kapur of Campaign looks at the evolution The Wall Street Journal. Kapur writes, "The transformation…
This position will be Hybrid in the office/market 3 days per week, and those days…
The Fund for American Studies presented James Bennet of The Economist with the Kenneth Y. Tomlinson Award…
The Wall Street Journal is experimenting with AI-generated article summaries that appear at the top…
Zach Cohen is joining Bloomberg Tax to cover the fiscal cliff and tax issues on…
Larry Avila has been named interim editor for Automotive Dive, an Industry Dive publication. He…